(HealthDay)—An algorithm that can classify patients with juvenile idiopathic arthritis (JIA) into seven distinct groups based on patterns of swollen or painful joints in the body can help predict disease course, according ...
Mar 11, 2019
0
1
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical ...
Nov 8, 2022
0
0
Juvenile idiopathic arthritis, or JIA, is the most common form of childhood arthritis. It appears to be an autoimmune disease, caused by antibodies attacking certain proteins in a person's own tissue. But no "autoantigens"—the ...
Feb 25, 2016
0
25
Pediatric rheumatic diseases are a varied group of rare diseases including juvenile forms of arthritis, lupus, fibromyalgia, and other conditions. Currently, there is considerable variability in how patients with these diseases ...
Jan 15, 2018
0
2
(Medical Xpress)—Scientists from The University of Manchester have identified 14 new genes which could have important consequences for future treatments of childhood arthritis.
Apr 22, 2013
0
0
Systemic juvenile idiopathic arthritis (SJIA) has long been considered a therapeutic orphan. Until now, the principal effective treatment has been high-dose steroids (prednisone) which are accompanied by several serious side ...
Dec 21, 2012
0
0
Across Europe, people with rheumatic and musculoskeletal diseases are less able to work than people in the general population. One of the most common reasons is that people with RMDs often have pain caused by their disease. ...
Oct 21, 2022
0
0
Mati Munoz lost her liver to hepatitis C, and the virus was attacking its transplanted replacement last year when her doctor prescribed a drug combination that could save the organ.
Mar 11, 2015
0
4
(HealthDay)—Children with arthritis who use a Web-based application to monitor health-related quality of life (HRQoL) have more discussions with their rheumatologist about psychosocial issues, and their physicians are more ...
Jan 7, 2013
0
0
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism shows that tocilizumab is efficacious and leads to a sustained clinically meaningful improvement in children with polyarticular ...
Jun 12, 2013
0
0
